治疗帕金森病的细胞疗法
Surabhi Shastry1,2, Junkai Hu1,2, Mingyao Ying2,3
1Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Pharmaceutics
|December 23, 2023
概括
诱导多能干细胞 (iPSCs) 通过再生丢失的多巴胺基神经元,为帕金森病 (PD) 提供了一种新的细胞疗法. 这种方法解决了神经退行,与目前的PD症状治疗不同.
科学领域:
- 神经科学是一个神经科学.
- 再生医学是一种再生医学.
- 干细胞生物学 干细胞生物学
背景情况:
- 帕金森病 (PD) 涉及多巴胺基神经元的逐渐丧失,导致运动症状,如震和刚性.
- 目前的PD疗法提供症状缓解,但不能阻止潜在的神经退行.
- 细胞重编程和诱导多能干细胞 (iPSCs) 提供了新的治疗途径.
研究的目的:
- 审查多巴胺在PD中的作用.
- 突出iPSCs治疗PD的再生潜力.
- 将基于iPSC的疗法与现有的PD治疗方法进行比较.
主要方法:
- 这是一个叙事评论.
- 它合成了关于多巴胺在PD中的影响的信息.
- 它研究了iPSC的差异化和治疗应用.
主要成果:
- iPSCs可以分化为多巴胺能神经元,这对于PD治疗至关重要.
- iPSC疗法对解决PD的神经退行性基础具有前景.
- 该评论探讨了增强移植神经元存活率的策略.
结论:
- iPSCs为帕金森病提供了一个有前途的再生方法.
- 这项技术有可能克服当前症状治疗的局限性.
- 进一步研究加强iPSC治疗对于长期有效性至关重要.
相关概念视频
Parkinson's Disease: Treatment
274
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
274
Parkinson's Disease: Overview
554
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
554
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K


